Replimune Group, Inc. (REPL)
14.69
-0.08
(-0.54%)
USD |
NASDAQ |
Aug 24, 16:00
14.69
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Market Cap : 1.234B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.240B |
| August 20, 2026 | 1.180B |
| August 19, 2026 | 1.244B |
| August 18, 2026 | 1.308B |
| August 17, 2026 | 1.229B |
| August 14, 2026 | 1.257B |
| August 13, 2026 | 1.276B |
| August 12, 2026 | 1.280B |
| August 11, 2026 | 1.129B |
| August 10, 2026 | 1.131B |
| August 07, 2026 | 997.57M |
| August 06, 2026 | 1.064B |
| August 05, 2026 | 978.54M |
| August 04, 2026 | 985.99M |
| August 03, 2026 | 985.16M |
| July 31, 2026 | 926.43M |
| July 30, 2026 | 447.50M |
| July 29, 2026 | 447.50M |
| July 28, 2026 | 442.54M |
| July 27, 2026 | 713.85M |
| July 24, 2026 | 802.35M |
| July 23, 2026 | 865.22M |
| July 22, 2026 | 889.21M |
| July 21, 2026 | 909.89M |
| July 20, 2026 | 869.35M |
| Date | Value |
|---|---|
| July 17, 2026 | 846.19M |
| July 16, 2026 | 787.46M |
| July 15, 2026 | 800.70M |
| July 14, 2026 | 816.42M |
| July 13, 2026 | 821.79M |
| July 10, 2026 | 909.06M |
| July 09, 2026 | 918.98M |
| July 08, 2026 | 919.81M |
| July 07, 2026 | 952.07M |
| July 06, 2026 | 948.76M |
| July 02, 2026 | 957.86M |
| July 01, 2026 | 928.08M |
| June 30, 2026 | 915.68M |
| June 29, 2026 | 926.43M |
| June 26, 2026 | 962.00M |
| June 25, 2026 | 920.64M |
| June 24, 2026 | 932.22M |
| June 23, 2026 | 909.39M |
| June 22, 2026 | 890.28M |
| June 18, 2026 | 811.44M |
| June 17, 2026 | 796.31M |
| June 16, 2026 | 699.16M |
| June 15, 2026 | 713.50M |
| June 12, 2026 | 707.13M |
| June 11, 2026 | 686.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 55.39B |
| Kalaris Therapeutics, Inc. | 97.12M |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sangamo Therapeutics, Inc. | 58.95M |
Market Cap Related Metrics
| Price to Book Value | 11.68 |
| Price | 14.69 |
| Earnings Yield | -22.32% |